We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
OSE Immunotherapeutics | TG:6OP | Tradegate | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
-0.08 | -1.17% | 6.77 | 6.74 | 6.79 |
High Price | Low Price | Open Price | Shares Traded | Last Trade |
---|---|---|---|---|
6.86 | 6.81 | 6.86 | 208 | 22:50:07 |
Date | Time | Source | Headline |
---|---|---|---|
06/1/2025 | 17:00 | UKREG | Ose Immunotherapeutics : Informations relatives au nombre total de droits.. |
18/12/2024 | 17:00 | UKREG | OSE Immunotherapeutics présentera les résultats d’induction de Phase 2 de .. |
18/12/2024 | 17:00 | UKREG | OSE Immunotherapeutics to Present Anti-IL-7R Lusvertikimab Phase 2.. |
11/12/2024 | 17:00 | UKREG | OSE Immunotherapeutics annonce des avancées cliniques positives de Tedopi®,.. |
11/12/2024 | 17:00 | UKREG | OSE Immunotherapeutics Announces Positive Clinical Progress for Late-Stage.. |
04/12/2024 | 17:00 | UKREG | OSE Immunotherapeutics : Informations Relatives au Nombre Total de Droits.. |
02/12/2024 | 17:00 | UKREG | OSE Immunotherapeutics Strengthens Leadership and Executive Committee |
02/12/2024 | 17:00 | UKREG | OSE Immunotherapeutics Renforce son Équipe de Direction et son Comité.. |
04/11/2024 | 17:00 | UKREG | Informations relatives au nombre total de droits de vote et d’actions.. |
04/11/2024 | 06:30 | UKREG | OSE Immunotherapeutics Annonce des Résultats Cliniquement Probants et.. |
1 Year OSE Immunotherapeutics Chart |
Intraday OSE Immunotherapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions